DBV Technologies has developed an innovative approach to influencing the immune response by targeting antigen presenting cells present in the skin. Immunoactive compounds are delivered to the immune system using DBV Technologies’ unique worldwide patented delivery system: VIASKIN®.
The key advantage of the VIASKIN® delivery system is its ability to deliver proteins epicutaneously, without any alteration in their antigenicity/allergenicity.
The key component of VIASKIN®’s ability in delivering proteins to the epidermis is its condensation chamber. This condensation chamber allows the release of soluble proteins from its backing and enables hyper hydration of the skin, which facilitates the delivery of the proteins to the epidermis. The application of VIASKIN® leads to a rapid, durable and homogenous increase in the hydration of all epidermis layers by more than 70%, after one hour of application.
The same degree of hydration was observed when VIASKIN® was applied to different age groups, ethnic groups, genders and at different temperatures. The size of the compound-holding condensation chamber is flexible and easily variable. The amount of active material can be precisely adjusted to a range from a few micrograms to several hundred, while the permeability of the polymeric film-backing can also be altered to meet specific product requirements and applications.
The key advantages of the VIASKIN® technology include:
CNIL number: 1544201 v 0
DBV technologies - siège social
Green Square - Bâtiment D
80/84 rue des Meuniers
Phone: +33 (0)1 55 42 78 78
Fax: +33 (0)1 43 26 10 83
SIRET: 441772522 00013
Executive editor: Pierre-Henri Benhamou
Hosting service: OVH www.ovh.com
Design : l’enchanteur www.lenchanteur.com
This website contains express or implied forward-looking statements, which are based on current expectations of management. These statements relate to, among other things, our expectations regarding management’s plans, objectives, and strategies. These statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. DBV assumes no obligation to update any forward-looking statements appearing on this website in the event of changing circumstances or otherwise, and such statements are current only as of the date they are made.
DBV may make improvements and/or changes to this website at any time. Although we attempt to periodically update information on this website, the information, materials and services provided on or through this website may occasionally be inaccurate, incomplete or out of date. DBV does not have a duty to update information contained in this website, and DBV will not be liable for any failure to update such information. We make no representation as to the completeness, accuracy or currency of any information on this website, and we undertake no obligation to update or revise the information contained on this website, whether as a result of new information, future events or circumstances or otherwise. It is your responsibility to verify any information contained in this website before relying upon it.
This website may contain links to websites operated by other parties. The linked sites are not under the control of DBV, and DBV is not responsible for the content available on any other Internet sites linked to this website. Such links do not imply DBV’s endorsement of material on any other site, and DBV disclaims all liability with regard to your access to such linked websites. DBV provides links to other Internet sites as a convenience to users, and access to any other Internet sites linked to this website is at your own risk.